Characterizing behavioral and psychological symptoms of dementia (BPSD) among geropsychiatric inpatients

Journal of the American Medical Directors Association

Volumn 3, Issue 3, 2002, Pages 146-151

  Tunis, Sandra L ^a   Edell, William S ^b   Adams, Bryan E ^b   Kennedy, John S ^a  

^a ELI LILLY AND COMPANY   (United States)

^b Mental Health Outcomes   (United States)

Author keywords

Aggression; BPSD; Cognitive impairment; Dementia; Long term care; PGDRS

Indexed keywords

AGED; ARTICLE; BEHAVIOR; DEMENTIA; DEMOGRAPHY; ELDERLY CARE; FEMALE; HOSPITAL PATIENT; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; RATING SCALE; SYMPTOMATOLOGY;

EID: 0012454232     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/S1525-8610(04)70457-0     Document Type: Article

References (41)

1. Walker M, Salek S, Bayer A. A review of quality-of-life in Alzheimer's Disease Part I: Issues in assessing disease impact. Pharmacoeconomics 1998;14:499-530.
2. Mintzer J, Hoernig K, Mirski D. Treatment of agitation in patients with dementia. Clin Geriatr Med 1998;14:147-175.
3. Rabins PV, Mace NL, Lucas MJ. The impact of dementia on the family. JAMA. 1982;248:333-335.
4. Lopez O, Wisniewski S, Becker J, et al. Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer's Disease. Arch Neurol 1999;56:1266-1272.
5. Blume L, Persely N, Mintzer J. The prevalence of dementia: The confusion of numbers. Am J Alzheimer's Care Related Disord Res 1992;3:3-18.
6. Lieberman M, Kramer J. Factors affecting decisions to institutionalize demented elderly. Gerontologist. 1991;31:371-374.
7. Steele C, Rovner B, Chase GA, Folstein M. Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. Am J Psychiatry 1990;147:1049-1051.
8. Lyketsos CG, Steele C, Galik E, et al. Physical aggression in dementia patients and its relationship to depression. Am J Psychiatry 1999;156:66-71.
9. Mega M, Cummings J, Fiovello T, Gornbein J. The spectrum of behavioral change in Alzheimer's disease. Neurology 1996;46:130-135.
10. Dyck G. Management of geriatric behavior problems. Psychiatr Clin North Am 1997;20:165-180.
11. Morriss RK, Rovner BW, German PS. Factors contributing to nursing home admission because of disruptive behavior. Int J Geriatr Psychiatry 1996;11:243-249.
12. National Center for Health Statistics. The National Nursing Home Survey. Summary for the United States. Vital and Health Statistics. Series 13, No 97 DHHS Publication No. PHS 89-1758. Washington, DC: U.S. Government Printing Office, 1989, 1985.
13. Meek P, McKeithan K, Schumock G. Economic Considerations in Alzheimer's Disease. Pharmacotherapy 1998;18:68S-73S.
14. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
15. Morriss RK, Rovner BW, German PS. Clinical and psychosocial variables associated with different types of behaviour problems in new nursing home admissions. Int J Geriatr Psychiatry 1995;10:547-555.
16. Wilkinson IM, Graham-White J. Psychogeriatric Dependency Rating Scale (PGDRS): A method of assessment for use by nurses. Br J Psychiatry 1980;137:558-565.
17. American Psychiatric Association. DSM-IV. Diagnostic and Statistical Manual of Mental Disorders. 4th Ed. Washington, DC, 1994.
18. Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 1992;40:922-935.
19. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatric Res 1983;17:37-49.
20. Nitcher RL, Burke WJ, Roccaforte WH, Wengel SP. A collateral source version of the Geriatric Depression Rating Scale. Am J Geriatr Psychiatry 1993;1:143-152.
21. Wilkinson I, Zissler LM. Standardised assessments for the elderly: Clinical applications. Nursing Times 1984;80:36-37.
22. Rovner BW, Kafonek S, Filipp L, Lucas MJ, Folstein MF. Prevalence of mental illness in a community nursing home. Am J Psychiatry 1986;143:1446-1449.
23. German PS, Rovner BW, Burton LC, Brant LJ, Clark R. The role of mental morbidity in the nursing home experience. Gerontologist. 1992;32:152-158.
24. Morriss RK, Rovner BW, German PS. Changes in behaviour before and after nursing home admission. Int J Geriatr Psychiatry 1994;9:965-973.
25. Answer Tree™ 2.0 Users' Guide, SPSS Inc. Chicago, Illinois; 1998.
26. Crum R, Anthony JC, Bassett SS, Folstein MF. Population Based Norms for the Mini-Mental State Examination by Age and Education Level. JAMA. 1993;269:2386-2391.
27. Martino-Saltzman D, Blasch B, Morris R, McNeal L. Travel behavior of nursing home residents perceived as wanderers and nonwanderers. Gerontologist. 1991;31:666-672.
28. Hamel M, Gold D, Andres D, et al. Predictors and consequences of aggressive behaviour by community-based dementia patients. Gerontologist. 1990;30:206-211.
29. Small GW. Psychopharmacological treatment of elderly demented patients. J Clin Psychiatry. 1988;49:8-13.
30. Tariot PN. Treatment strategies for agitation and psychosis in dementia. J Clin Psychiatry 1996;57:21-29.
31. Maixner SM, Mellow AM, Tandon R. The efficacy, safety, and tolerability of antipsychotics in the elderly. J Clin Psychiatry 1999;60:29-41.
32. Kumar V, Brecher M. Psychopharmacology of atypical antipsychotics and clinical outcomes in elderly patients. J Clin Psychiatry 1999;60:5-9.
33. Zarate CA, Jr, Baldessarini RJ, Siegel AJ, et al. Risperidone in the elderly: A pharmacoepidemiologic study. J Clin Psychiatry 1997;58:311-317.
34. Irizarry MC, Ghaemi SN, Lee-Cherry ER, et al. Risperidone treatment of behavioral disturbances in outpatients with dementia. J Neuropsychiatry Clin Neurosci 1999;11:336-342.
35. Madhusoodanan S, Suresh P, Brenner R, Pillai R. Experience with the atypical antipsychotics-risperidone and olanzapine in the elderly. Ann Clin Psychiatry. 1999;11:113-118.
36. Street J, Clark WS, Mitan S, et al. Olanzapine in the treatment of psychiatric disturbances associated with Alzheimer's disease. Neurology. 1999;52:396-397.
37. Davidson M, Weiser M, Soares K. Novel antipsychotics in the treatment of psychosis and aggression associated with dementia: A meta-analysis of randomized controlled clinical trials. Int Psychogeriatr 2000;12:271-277.
38. DeDeyn PP, Rabheru K, Rasmussen A, Bocksberger JP, Dautzenberg PLJ, Eriksson S, and Lawlor BA. A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia, Neurology 1999;53:946-955.
39. Katz IR, Jeste DV, Mintzer JE, Clyde C, Napolitano J, and Brecher M. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: A randomized, double-blind trial. J Clin Psychiatry 1999;60:107-115.
40. Edell W, Tunis S. Antipsychotic Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD) in Geropsychiatric Inpatients. Am J Geriatr Psychiatry 2001;9:289-297.
41. Cummings JL, Jeste DV. Alzheimer's disease and its management in the year 2010. Psychiatr Serv 1999;50:1173-1177.